These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23103524)

  • 1. Structural and functional interaction of (±)-2-(N-tert-butylamino)-3'-iodo-4'-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Targowska-Duda KM; Aggarwal S; Lapinsky DJ; Jozwiak K
    Neurochem Int; 2012 Dec; 61(8):1433-41. PubMed ID: 23103524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Ortells MO
    Neurochem Int; 2016 Nov; 100():67-77. PubMed ID: 27612850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bupropion binds to two sites in the Torpedo nicotinic acetylcholine receptor transmembrane domain: a photoaffinity labeling study with the bupropion analogue [(125)I]-SADU-3-72.
    Pandhare A; Hamouda AK; Staggs B; Aggarwal S; Duddempudi PK; Lever JR; Lapinsky DJ; Jansen M; Cohen JB; Blanton MP
    Biochemistry; 2012 Mar; 51(12):2425-35. PubMed ID: 22394379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Gumilar F; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW; Bouzat C
    Biochemistry; 2009 Jun; 48(21):4506-18. PubMed ID: 19334677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
    Arias HR; Ortells MO; Feuerbach D
    Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Feuerbach D; Targowska-Duda KM; Jozwiak K
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1330-9. PubMed ID: 21642011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban).
    Lapinsky DJ; Aggarwal S; Nolan TL; Surratt CK; Lever JR; Acharya R; Vaughan RA; Pandhare A; Blanton MP
    Bioorg Med Chem Lett; 2012 Jan; 22(1):523-6. PubMed ID: 22119468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel.
    Arias HR; Targowska-Duda KM; Feuerbach D; Sullivan CJ; Maciejewski R; Jozwiak K
    Neurochem Int; 2010 Mar; 56(4):642-9. PubMed ID: 20117161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Yuan XJ; Jozwiak K; Moaddel R; Wainer IW
    Int J Biochem Cell Biol; 2010 Sep; 42(9):1525-35. PubMed ID: 20684041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Targowska-Duda KM; Jozwiak K
    Neurochem Int; 2010 Sep; 57(2):153-61. PubMed ID: 20493225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory mechanisms and binding site location for serotonin selective reuptake inhibitors on nicotinic acetylcholine receptors.
    Arias HR; Feuerbach D; Bhumireddy P; Ortells MO
    Int J Biochem Cell Biol; 2010 May; 42(5):712-24. PubMed ID: 20079457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.
    Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW
    Int J Biochem Cell Biol; 2010 Jun; 42(6):1007-18. PubMed ID: 20223294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions?
    Arias HR
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2098-108. PubMed ID: 19497387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors.
    Gerzanich V; Peng X; Wang F; Wells G; Anand R; Fletcher S; Lindstrom J
    Mol Pharmacol; 1995 Oct; 48(4):774-82. PubMed ID: 7476906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor.
    Arias HR; Fedorov NB; Benson LC; Lippiello PM; Gatto GJ; Feuerbach D; Ortells MO
    J Pharmacol Exp Ther; 2013 Jan; 344(1):113-23. PubMed ID: 23010362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational states.
    Arias HR; Rosenberg A; Feuerbach D; Targowska-Duda KM; Maciejewski R; Jozwiak K; Moaddel R; Glick SD; Wainer IW
    Biochim Biophys Acta; 2010 Jun; 1798(6):1153-63. PubMed ID: 20303928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
    Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
    Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the binding site(s) for antidepressants on the Torpedo nicotinic acetylcholine receptor: [3H]2-azidoimipramine photolabeling and molecular dynamics studies.
    Sanghvi M; Hamouda AK; Jozwiak K; Blanton MP; Trudell JR; Arias HR
    Biochim Biophys Acta; 2008 Dec; 1778(12):2690-9. PubMed ID: 18817747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.
    Arias HR; Gu RX; Feuerbach D; Guo BB; Ye Y; Wei DQ
    Biochemistry; 2011 Jun; 50(23):5263-78. PubMed ID: 21510634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.